| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Common Stock | Award | $0 | +15.9K | +8.75% | $0.00 | 197K | Feb 24, 2022 | Direct | F1, F2 |
| transaction | RGEN | Common Stock | Tax liability | -$221K | -1.17K | -0.59% | $189.21 | 196K | Feb 24, 2022 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Stock Option (Right to Buy) | Award | $0 | +20.3K | $0.00 | 20.3K | Feb 24, 2022 | Common Stock | 20.3K | $189.21 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Mr. Hunt was awarded 15,855 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
| F2 | The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 1,000 shares, first reflected in a Form 5 filed on February 10, 2021. |
| F3 | Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. |
| F4 | One third of the stock options will vest and become exercisable annually on February 24, 2023, February 24, 2024 and February 24, 2025. |